The pathogenesis of bronchial asthma is not yet fully understood. Recently much attention has been given to the hypothesis that intracellular free calcium ([Ca2+]i) metabolism is abnormal in various diseases. In this study weinvestigated whether [Ca2+]i exists abnormally in subjects with bronchial asthma. The [Ca2+]i in 32 treated or untreated subjects with bronchial asthma were compared with 63 normal subjects. Resting levels of [Ca2+]i were estimated by loading the fluorescent indicator Fura-2 in washed platelets. The [Ca2+]i level in the control subjects was 129.7+18.0 nM(mean±SD). However, in that of the bronchial asthma patients was 152.7+44.1 nM, significantly higher than that of the control subjects (p<0.05). It is well recognized that an increase of [Ca2+]i in vascular smoothmuscle involves contraction. The findings suggest that the same phenomenon is quite possible in the tracheal smooth muscle and that it plays an important role in the pathogenesis of bronchial asthma. (Internal Medicine 34: 722-727, 1995) 
Introduction
Bronchial asthma is characterized by reversible airway obstruction which is induced by the constriction of bronchial smooth muscle, secretion of mucus and mucosal edema ( 1) . The important role of calcium ions in the regulation of skeletal muscle construction was established in 1970s by Ebashi (2). Since then, [Ca2+]i levels have been used as a reliable indicator of smooth muscle constriction. The relationship between [Ca2+] i and muscle tension has been investigated by radioactive 45Ca2+ flux experiments. In general, there is a good correlation between the ratio of 45Ca2+influx and smooth muscle constriction (3-6). However, it is difficult to directly measure [Ca2+]i in patients by this method. In the 1980s, Tsien synthesized a new intracellular Ca2+ indicator, Quin2, which was followed by the improved indicators, Fura-2 and indo-1 (7). At present, these indicators are widely used to examinethe changes of [Ca2+]i in hypertensive study. To our knowledge, measurement of [Ca2+]i in patients with bronchial asthma using this method has not been previously reported. In this study we measured [Ca2+] i directly in platelets obtained from patients with bronchial asthma using a fluorescence method.
Materials and Methods
Subjects: 32 (14 males; 18 females) treated or untreated patients with bronchial asthma and 63 (37 males; 26 females) healthy control subjects were investigated in this study. The meanage of asthmatic patients was 49±21 SDin males and 38±21 SD in females. On the other hand, the meanage of control subjects was 39±17 SDin males and 44±17 SDin females.
Preparation of platelet-rich plasma (PRP)
Figures 1 and 2 schematically illustrate the whole procedure and the device for measuring the [Ca2+]i. Venous blood (9ml) was collected with a 21 gauge needle. Blood was drawn into a polypropylene syringe containing 1 ml of 3.8% sodium citrate as the anticoagulant. Whenwe collect the blood sample, we usually release the tourniquet and take it slowly and steadily for a few minutes in order to prevent activation of platelets (8).
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connected and a 5 ml of blood sample was collected which was used for measuring the sodium, potassium, total calcium and magnesium in serum. The blood was immediately centrifuged at 800 rpm for 15 minutes at 20°C. The PRP was removed and the number of platelets was counted; citric acid was added and centrifuged at 2,600 rpm for 15 minutes at 20°C to prepare the platelet pellet. The platelet pellet was suspended in 10 mMN-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid (HEPES) buffer containing 1 jiM Fura-2-acetoxylmethyl ester (Fura-2-AM)to a final concentration of 105 cell/pl and then incubated in a water bath for 45 minutes at 37°C. The platelet suspension was then placed on a 9x300 mmSepharose CL-2B column which had been previously equilibrated with 100 ml of HEPES buffer. The platelet fraction in the elute, which was identified by Internal Medicine Vol. 34, No. 8 (August 1995) the appearance of turgidity, was collected in 1 ml vials and then 1 mMcalcium chloride was added and incubated for45 minutes at37°C.
Estimation of [Ca2+]i
Fluorescence intensity was measured at an emission wavelength of 500 nmand sequential excitation wavelength of 340, 380 nmusing a fluorometric spectrophotometer (CAF-100: Japan Spectroscopic Co. Ltd., Tokyo, Japan). Specimens were then lysed with 0.5% Triton X-100 (Sigma Chemical Co. Ltd., St. Louis, MO, USA), and the maximal ratio of fluorescence 340/380 was recorded. After 10 ml ethylene glycol-bis (j3-aminoethyl ether) N,N,N' ,N'-tetraacetic acid (EGTA) was added, the minimal ratio of 340/380 was then measured. Using this ratio of 340/380,
[Ca2+]i was calculated by the following equation (9): [Ca2+] i=Kdx(R-Rmin/Rmax-R)x/3 where Kd represents the dissociation constant of Fura-2 for calcium (224 nM), R is the ratio of fluorescence at excitation wavelengths 340 and 380 nm in intact cell suspension, Rmax and Rmin are the ratio of fluorescence at 340 and 380 nmunder calcium-saturated and calcium-free conditions, respectively, and j3 is the fluorescence ratio at 380 nm of Rminto Rmax. Rmax was determined by lysing the cell with 50 jjJM digitonin in the presence of 1 mMcalcium. Rmin was then determined by the successive addition of 10 mMEGTA followed by adjustment of pH to 8.3 with 30 mMTris.
Other biochemical analysis Concentration of sodium and potassium in serum were measured by 480 Flame Photometer (Ciba-Corning Diagnostic Co. Ltd., Tokyo, Japan). Total measurement of calcium and magnesiumwere carried out by Ca-Mgfluorescent analyzing Meter 30/20 (Jookoo Co., Ltd., Tokyo, Japan). Serum IgE was measured by standard radioimmunoassay.
Statistical analysis
All data are presented as mean±SD unless otherwise noted. Statistical comparisons were performed using unpaired Student's t-test with p<0.05 considered as significant. Table 1 shows [Ca2+]i concentrations in healthy normal subjects of different sexes and age groups. There were no significant differences observed in both sexes and between age groups. Thus we used the value of 129.7+18.0 nM (combined 37 males and 26 females) as amean control value. The deviation of this control data was about 14%indicating that our method can be considered accurate and reproducible. Figure 3 . Intracellular free calcium concentration in normal subjects and in bronchial asthma patients.
Results
Increased Platelet-Free Calcium in Bronchial Asthma higher than that of normal subjects (p<0.05), as shown in Fig. 3.
Serum calcium, sodium, potassium and magnesiumin normal subjects and in bronchial asthma patients are summarized in Table 3 . In each parameter a similar value was obtained and no significant differences were observed the two groups. Figure   4 shows IgE(IU/ml) 3,000 3,500 4,000 Figure 4 . Relationship between intracellular free calcium concentrations and serum calcium (a), eosinophil (b) and IgE (c) in bronchial asthma patients. which changes in [Ca ] i concentrations within the cell are not clearly understood, particularly in the smooth muscle of the airway. In the second half of 1970s and the first half of 1980s several investigators have reported that an increase of [Ca2+]i concentration activates not only respiratory smooth muscles, but also mast cell, bronchial mucus glands and the vagi. Calcium antagonists that block Ca2+ influx through specific Ca2+channels in cytoplasmic membraneswere therefore expected to be effective in the treatment of bronchial asthma ( 1 , 4-6) . However, these studies were performed using in vitro studies or animal studies, because it was difficult to measure the concentration of [Ca2+]i directly in patients with bronchial asthma. In 1983, Tsien and his colleagues synthesized a new intracellular Ca2+indicator, facilitating the direct measurement of [Ca2+]i concentration in patients using the blood components.
In this study, we measured the concentration of [Ca2+]i in patients with bronchial asthma and found that it was significantly higher than that in normal subjects. To our knowledge, measurement of the concentration of [Ca2+]i in patients with bronchial asthma using the fluorescence method has not been previously reported. Although the mechanismof the increase of [Ca2+]i concentration in bronchial asthma is not clear in the present study, calcium ion, when stimulated, is mobilized from intracellular sources such as the inner surface of plasma membrane and sacroplasmic reticulum ( 16, 29) and from extracellular sources through transmembrane-specific Ca2+ channels ( 1 6, 30 
